Healthcare Global Enterprises Limited — Financials & Forensics
Sector: Healthcare · NSE: HCG · BSE: 539787 · ISIN: INE075I01017
08 May 2026
FY26 headline numbers
| Line item | FY26 |
|---|---|
| Revenue from operations | ₹2,545 Cr |
| EBITDA | ₹421 Cr |
| EBITDA margin | 16.6% |
| Profit after tax | ₹21 Cr |
Deeper analysis
See Healthcare Global Enterprises Limited's full quarterly & annual history
Last 20 quarters of P&L · 7-year balance sheet · cash flow · shareholding pattern · concall transcripts & audio summaries · insider-trade history · bulk & block deals — all behind a free sign-up.
Sign up free →About Healthcare Global Enterprises Limited on Indian Stock Alerts
Indian Stock Alerts tracks Healthcare Global Enterprises Limited's SEBI / exchange filings in real time. Every quarterly result, audited annual report, shareholding pattern update, insider trade and corporate announcement is automatically parsed and surfaced as a structured data point — with a link back to the underlying filing.
Data points refreshed daily include closing price, 1Y change, market cap, P/E, ROE, dividend yield, RPT volume, audit / governance / accrual flags. Quarterly results numbers refresh within minutes of the company filing them with BSE / NSE.